Skip to content

Nebulo 28 Nebulizer Kit

by Inspiron Corp. 510(k)

Active United States

510(k) K841158

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK841158 Date30 Mar 1984ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
BTT
Device Class
Class II
Regulation
21 CFR Part 868.5450
Advisory Committee
Anesthesiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Nebulo 28 Nebulizer Kit is a Humidifier, Respiratory Gas (Direct Patient Interface) device, designed to convert liquid medication into a fine aerosol mist for inhalation therapy. It delivers therapeutic agents directly to the respiratory tract, facilitating treatment of conditions such as asthma, chronic obstructive pulmonary disease (COPD), or other respiratory disorders requiring nebulized medication administration.

This device is intended for single-use in clinical or home settings and is classified as a Class II medical device under FDA regulations. Supplied as a complete kit, it requires no sterilization beyond manufacturer-provided packaging and is intended for direct patient use without reprocessing. The Nebulo 28 Nebulizer Kit holds an FDA 510(k) clearance (K841158) under the BTT product code, with a decision of Substantially Equivalent to the predicate device. Storage instructions and MRI safety are not specified in the available data.

Other devices from Inspiron Corp.

See all devices from Inspiron Corp. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Nebulo 28 Nebulizer Kit used for?

    The Nebulo 28 Nebulizer Kit is designed to convert liquid medication into a fine aerosol mist, enabling direct inhalation therapy. This is particularly useful for treating respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), or other disorders requiring nebulized medication delivery. The device facilitates targeted treatment by delivering therapeutic agents straight to the respiratory tract.

  • Is the Nebulo 28 Nebulizer Kit intended for single-use or reuse?

    The Nebulo 28 Nebulizer Kit is explicitly intended for single-use only in both clinical and home settings. It is supplied sterile within its manufacturer-provided packaging, eliminating the need for additional sterilization or reprocessing. This design ensures patient safety and hygiene by preventing cross-contamination.

  • How is the Nebulo 28 Nebulizer Kit supplied, and what does the kit include?

    The Nebulo 28 Nebulizer Kit is supplied as a complete, ready-to-use unit in its original packaging. No additional components or accessories are required beyond what is included in the kit. The device is pre-sterilized by the manufacturer, so no further sterilization steps are necessary before use.

  • Does the Nebulo 28 Nebulizer Kit require any special storage conditions?

    The provided data does not specify any special storage conditions (e.g., temperature, humidity, or light exposure) for the Nebulo 28 Nebulizer Kit. However, standard medical device storage practices—such as keeping it in a clean, dry environment and protecting it from physical damage—are recommended. Always follow the manufacturer’s instructions if additional guidance is provided elsewhere.

  • What regulatory clearance does the Nebulo 28 Nebulizer Kit hold?

    The Nebulo 28 Nebulizer Kit holds an FDA 510(k) clearance (K841158) under the BTT product code. This clearance indicates that the device is classified as Substantially Equivalent to a predicate device and meets FDA requirements for safety and effectiveness as a Class II medical device. The clearance was issued in 1984, and no additional regulatory details beyond this are provided in the available data.